XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Net Sales and Profit by Segments Net sales and profit by each reportable segment for the three months ended March 31, 2022 and 2021 are as follows:
Three Months Ended March 31,
Dollars in thousands20222021
Segment Net Sales
Codman Specialty Surgical$247,308 $241,241 
Tissue Technologies
129,330 118,830 
Total revenues$376,638 $360,071 
Segment Profit
Codman Specialty Surgical$110,160 $106,778 
Tissue Technologies
53,893 50,011 
Segment profit164,053 156,789 
Amortization(3,894)(4,527)
Corporate and other(113,995)(121,548)
Operating income$46,164 $30,714 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20222021
United States$263,351 $247,793 
Europe43,744 45,819 
Asia Pacific47,717 47,295 
Rest of World21,826 19,164 
Total Revenues$376,638 $360,071 
Schedule of Geographic Revenue by Area Net sales and profit by each reportable segment for the three months ended March 31, 2022 and 2021 are as follows:
Three Months Ended March 31,
Dollars in thousands20222021
Segment Net Sales
Codman Specialty Surgical$247,308 $241,241 
Tissue Technologies
129,330 118,830 
Total revenues$376,638 $360,071 
Segment Profit
Codman Specialty Surgical$110,160 $106,778 
Tissue Technologies
53,893 50,011 
Segment profit164,053 156,789 
Amortization(3,894)(4,527)
Corporate and other(113,995)(121,548)
Operating income$46,164 $30,714 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20222021
United States$263,351 $247,793 
Europe43,744 45,819 
Asia Pacific47,717 47,295 
Rest of World21,826 19,164 
Total Revenues$376,638 $360,071